Fingerprint
Dive into the research topics of 'Dermatologic side effects associated with the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Dermatologic side effects associated with the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886)
Yevgeniy Balagula, Katherine Barth Huston, Klaus J. Busam, Mario E. Lacouture, Paul B. Chapman, Patricia L. Myskowski
Research output: Contribution to journal › Review article › peer-review
72
Scopus
citations